Mental Health DailyResearch. Evidence. Perspective.Published research on side effects.
Reports suggest that nearly 20% of all people in the United States are taking a psychiatric drug. This means that 1 out of every 5 people you see is on some sort of mind-altering medication.…
Read articleGabapentin (Neurontin) is a medication that was developed as a treatment for neuropathic pain and as an adjunct for seizures. It is also commonly prescribed off-label for conditions such as:…
Read articleGabapentin is a drug that was approved by the FDA in 1993 as an adjunct treatment for epileptic seizures. It has since attained approval for the treatment of partial seizures in adults and c…
Read articleNamenda (Memantine) is a drug that was approved by the FDA in 2003 for the treatment of Alzheimer’s disease. Research suggests that Namenda has a small effect in reducing symptoms among thos…
Read articleSubutex and Suboxone are drugs that were approved by the FDA in 2002 for the treatment of opioid dependence. Both drugs contain the active ingredient buprenorphine, a semisynthetic opioid th…
Read articleVyvanse (Lisdexamfetamine) is a drug developed by Shire Pharmaceuticals as a successor to Adderall. Vyvanse was first approved for the treatment of attention-deficit/hyperactivity disorder (…
Read articleMethylphenidate is considered the first medication approved for the treatment of the condition known as “hyperactivity” in the 1960s. As attention-deficit/hyperactivity disorder gained more …
Read article